Issues with recruitment to randomised controlled trials in the drug and alcohol field: a literature review and Australian case study

References

• Morley K C, Teesson M, Reid S C, et al. Naltrexone versus acamprosate in the treatment of alcohol dependence: a multi-centre, randomized, double-blind, placebo-controlled trial. Addiction 2006; 101: 1451–1462
   PubMed Web of Science ®Google Scholar
• Ashery R S, McAuliffe W E. Implementation issues and techniques in randomized trials of outpatient psychosocial treatments for drug abusers: recruitment of subjects. Am J Drug Alcohol Abuse 1992; 18: 305–329
   PubMed Web of Science ®Google Scholar
• Cottler L B, Compton W M, Ben-Abdallah A, et al. Achieving a 96.6 percent follow-up rate in a longitudinal study of drug abusers. Drug Alcohol Depend 1996; 41: 209–217
   PubMed Web of Science ®Google Scholar
• Latt N C, Jurd S, Houseman J, et al. Naltrexone in alcohol dependence: a randomised controlled trial of effectiveness in a standard clinical setting. Med J Aust 2002; 176: 530–534
   PubMed Web of Science ®Google Scholar
• Shakeshaft A P, Bowman J A, Burrows S, et al. Community-based alcohol counselling: a randomized clinical trial. Addiction 2002; 97: 1449–1463
   PubMed Web of Science ®Google Scholar
• Feeney G F, Connor J P, Young R M, et al. Alcohol dependence: the impact of cognitive behaviour therapy with or without naltrexone on subjective health status. Aust NZ J Psychiatry 2004; 38: 842–848
   PubMed Web of Science ®Google Scholar
• Morris P L. Naltrexone for alcohol dependence: a randomized controlled trial. Addiction 2001; 96: 1565–1573
   PubMed Web of Science ®Google Scholar
• Feeney G F, Young R M, Connor J P, et al. Cognitive behavioural therapy combined with the relapse-prevention medication acamprosate: are short-term treatment outcomes for alcohol dependence improved?. Aust NZ J Psychiatry 2002; 36: 622–628
   PubMed Web of Science ®Google Scholar
• Chick J, Howlett H, Morgan M Y, et al. United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol. Alcohol Alcohol 2000; 35: 176–187
   PubMed Web of Science ®Google Scholar
• Rubio G, Jimenez-Arriero M A, Ponce G, et al. Naltrexone versus acamprosate: one year follow-up of alcohol dependence treatment. Alcohol Alcohol 2001; 36: 419–425
   PubMed Web of Science ®Google Scholar
• Chick J, Anton R, Checinski K, et al. A multicentre, randomized, double-blind, placebo-controlled trial of naltrexone in the treatment of alcohol dependence or abuse. Alcohol Alcohol 2000; 35: 587–593
   PubMed Web of Science ®Google Scholar
• Poldrugo F. Acamprosate treatment in a long-term community-based alcohol rehabilitation programme. Addiction 1997; 92: 1537–1546
   PubMed Web of Science ®Google Scholar
• Kranzler H R, Modesto-Lowe V, Van Kirk J. Naltrexone vs. nefazodone for treatment of alcohol dependence. A placebo-controlled trial. Neuropsychopharmacology 2000; 22: 493–503
   PubMed Web of Science ®Google Scholar
• Krystal J H, Cramer J A, Krol W F, et al. Naltrexone in the treatment of alcohol dependence [see comments]. New Engl J Med 2001; 345: 1734–1739
   PubMed Web of Science ®Google Scholar
• Mattick R, Digiusto E, Doran C, et al. National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD): report of results and recommendations. National Drug and Alcohol Research Centre, Sydney 2001
   Google Scholar
• Pich J, Carne X, Arnaiz J-A, et al. Role of a research committee in follow-up and publication of results. Lancet 2003; 361: 1015–1016
   PubMed Web of Science ®Google Scholar
• Easterbrook P J, Matthews D R. Fate of research studies. J R Soc Med 1992; 85: 71–76
   PubMedGoogle Scholar
• Jaskiw G E, Blumer T E, Gutierrez-Esteinou R, et al. Comparison of inpatients with major mental illness who do and do not consent to low-risk research. Psychiatry Res 2003; 119: 183–188
   PubMedGoogle Scholar
• Ross S, Grant A, Counsell C, et al. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol 1999; 52: 1143–1156
   PubMed Web of Science ®Google Scholar
• Bale R N, Van Stone W W, Kuldau J M, et al. Therapeutic communities vs methadone maintenance. A prospective controlled study of narcotic addiction treatment: design and one-year follow-up. Arch Gen Psychiatry 1980; 37: 179–193
   PubMed Web of Science ®Google Scholar
• Proudfoot H, Teesson M. Who seeks treatment for alcohol dependence? Findings from the Australian National Survey of Mental Health and Wellbeing. Soc Psychiatry Psychiatr Epidemiol 2002; 37: 451–456
   PubMed Web of Science ®Google Scholar
• McKeganey N. To pay or not to pay: respondents' motivation for participating in research. Addiction 2001; 96: 1237–1238
   PubMed Web of Science ®Google Scholar
• Koocher G P. Questionable methods in alcoholism research. J Consult Clin Psychol 1991; 59: 246–248
   PubMed Web of Science ®Google Scholar
• Bentley J P, Thacker P G. The influence of risk and monetary payment on the research participation decision making process. J Med Ethics 2004; 30: 293–298
   PubMed Web of Science ®Google Scholar
• Dickert N, Grady C. What's the price of a research subject? Approaches to payment for research participation. N Engl J Med 1999; 341: 198–203
   PubMed Web of Science ®Google Scholar
• Cunningham J A, Breslin F C. Only one in three people with alcohol abuse or dependence ever seek treatment. Addict Behav 2004; 29: 221–223
   PubMed Web of Science ®Google Scholar
• Commander M J, Odell S O, Williams K J, et al. Pathways to care for alcohol use disorders. J Public Health Med 1999; 21: 65–69
   PubMedGoogle Scholar
• Isenhart C E, Van Krevelen S. Relationship between readiness for and processes of change in a sample of alcohol dependent males. J Subst Abuse 1998; 10: 175–184
   PubMedGoogle Scholar
• Brooker C, Peters J, McCabe C, et al. The views of nurses to the conduct of a randomised controlled trial of problem drinkers in an accident and emergency department. Int J Nurs Stud 1999; 36: 33–39
   PubMed Web of Science ®Google Scholar
• Rojavin M A. Recruitment index as a measure of patient recruitment activity in clinical trials. Contemp Clin Trials 2005; 26: 552–556
   PubMedGoogle Scholar
• Dickinson C J. Clinical research in the NHS today. J R Coll Physicians Lond 1994; 28: 460–463
   PubMedGoogle Scholar
• Peto V, Coulter A, Bond A. Factors affecting general practitioners' recruitment of patients into a prospective study. Fam Pract 1993; 10: 207–211
   PubMed Web of Science ®Google Scholar
• Richardson A, Sutherland M, Wells E, et al. Factors affecting general practitioner involvement in a randomised controlled trial in primary care. NZ Med J 2002; 115: 153–155
   PubMedGoogle Scholar
• Bell-Syer S E, Klaber Moffett J A. Recruiting patients to randomized trials in primary care: principles and case studies. Fam Pract 2000; 17: 187–191
   PubMedGoogle Scholar
• Roche A M, Parle M D, Stubbs J M, et al. Management and treatment efficacy of drug and alcohol problems: what do doctors believe?. Addiction 1995; 90: 1357–1366
   PubMed Web of Science ®Google Scholar
• Roche A M, Freeman T. Brief interventions: good in theory but weak in practice. Drug Alcohol Rev 2004; 23: 11–18
   PubMed Web of Science ®Google Scholar
• Andreasson S, Parmander M, Allebeck P. A trial that failed, and the reasons why: comparing the Minnesota model with outpatient treatment and non-treatment for alcohol disorders. Scand J Soc Med 1990; 18: 221–224
   PubMedGoogle Scholar
• Hunt C J, Shepherd L M, Andrews G. Do doctors know best? Comments on a failed trial. Med J Aust 2001; 174: 144–146
   PubMedGoogle Scholar